patrick.net

A Smoking Gun?

The World's Least Interesting Conspiracy Theory just got more interesting as new evidence emerged about Pfizer's mysterious shutdown of its vax clinical trial until the day after the 2020 election.

The House Judiciary Committee released today what might be smoking gun evidence that, as I’ve been arguing for most of this decade, Pfizer shut down work on its massively important clinical trial of its covid vax until the day after the 2020 election for political reasons.

https://judiciary.house.gov/media/press-releases/new-information-suggests-senior-pfizer-executives-conspired-delay-covid-19

"New Information Suggests Senior Pfizer Executives Conspired to Delay COVID-19 Vaccine Clinical Testing to Influence 2020 Election"

If Trump had been able to crow about the success of his vaccine strategy for the last 24 hours of his 2020 campaign, that might well have flipped the fraction of one percent of the vote needed to get Trump to a 269-269 tied in the Electoral College, after which he likely would have been re-elected by the House voting as states.

As I may have mentioned once or twice over the last five years, Pfizer senior vice president William Gruber publicly admitted to reporter Matthew Herper of StatNews on November 9, 2020 that, stunningly, Pfizer had put all work on their crucial clinical trial of their vaccine on ice from late October 2020 until the day after the election:

In their announcement of the results, Pfizer and BioNTech revealed a surprise. The companies said they had decided not to conduct the 32-case analysis “after a discussion with the FDA.”

These FDA-confidential files, shared with the FDA, expose a chilling cover-up.

Here’s what Pfizer knew—and when:

1. Vaccine Failure Known Early: Just ONE MONTH after the November 2020 rollout, Pfizer’s internal records confirmed the vaccines didn’t stop COVID. Shockingly, the third most common side effect reported? COVID itself. While media and influencers pushed the jab, Pfizer knew it was failing.

2. Flood of Adverse Events: Within weeks, Pfizer was overwhelmed by reports of severe side effects. They planned to hire 2,400 full-time staff just to process the paperwork for the flood of adverse events they knew was coming. The public? Kept in the dark.

3. Heart Damage in Teens: By May 2021, Pfizer knew the vaccine caused heart damage in 35 minors within a week of injection. Yet, the FDA and U.S. government delayed warning parents until August 2021—four months later. During that time, young adults faced relentless propaganda: “Do it for grandma.” No mention of the elevated heart risks.

4. Toxic Biodistribution: The CDC claimed the vaccine’s materials (lipid nanoparticles, mRNA, spike protein) stayed at the injection site. False. Pfizer’s own data showed these materials biodistribute across the body within 48 hours, accumulating in the brain, liver, spleen, adrenals, and—most alarmingly—in women’s ovaries. These industrial fats, coated in polyethylene glycol, have no known mechanism for leaving the ovaries, building up with each dose.

Dr. Robert Chandler, a respected pathologist, confirmed these materials persist in organs over time, with no clear way for the body to expel them. For women, this raises profound concerns about long-term health impacts.

Pfizer has delayed a major study into the risks of heart damage in children who received the company’s Covid mRNA “vaccines,” pushing the probe back until for another five years.

The delays mean that the results of the study won’t be known until ten years after the injections were first rolled out for public use.

The Pfizer-sponsored clinical trial assessing long-term myocarditis outcomes in youth following Covid mRNA “vaccination” is now expected to be completed by November 2030.

As Slay News has previously reported, Myocarditis is a “silent killer” at the center of the sudden deaths crisis that emerged after the Covid injections were rolled out for public use in early 2021.

Donald Trump:

"I was honored to have Albert [Bourla here]... He's done a fantastic job with...COVID. He did a fantastic job ..."

MONUMENTAL MAHA FAIL: Pfizer Strikes $70 Billion Deal with U.S. to Expand Its mRNA Empire, Lower Drug Prices

‘Landmark agreement’ lets Pfizer expand its disastrous mRNA platform — sweeping a massive trail of death and destruction under the rug.

And just like that the MAHA movement implodes on itself and totally negates today’s earlier winning…

…by unleashing ever more deadly Modified mRNA slow kill bioweapon “vaccines” on the American people with a classic bait-and-switch of cheaper drug prices for the very adverse events that these depopulation injections have already wreaked on society as a whole.

This quid pro quo BigPharma deal is as ugly and dirty as it gets, and RFK Jr. had a difficult time during today’s most unfortunate press conference containing his disgust as Pfizer’s criminally deranged lizard-man CEO Albert Bourla locked in a deal with President Operation Warp Speed:




We need MASS ARRESTS of these BigPharma CEO’s, not scammy ‘TrumpRx’ deals with them.




The message is clear: accountability is off the table, and Pfizer’s genetic empire now stands shielded by the U.S. government itself.

A major new study has found that Pfizer’s popular birth control injection Depo-Provera has triggered surges in deadly and disabling brain tumors among healthy women who received the jab.

The alarming finding confirms long-standing concerns that the pharmaceutical giant allegedly ignored for decades. ...

Their findings were published in JAMA Neurology.

https://jamanetwork.com/journals/jamaneurology/article-abstract/2838202

Depo-Provera has been marketed for decades as a convenient, long-acting contraceptive.

It is used by roughly one in four sexually active American women.

But the study found that risk was particularly high among women who began using the injections after age 31 or stayed on the drug for more than four years.

In addition, a French study published in The British Medical Journal (BMJ) found that women who used Depo-Provera for over a year had a 5.6 times greater risk of developing a meningioma.

Doing the math, that's a 91% payout ratio, which is unsustainable for a pharma.